COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Résultats T2/S1 2026 - Trajectoire solide du chiffre d’affaires à +9,7 % au S1, avec un T2 à +8,7 %. Rentabilité en hausse, avec un résultat opérationnel ajusté progressant de +15 %.
28/07/2026
Trajectoire solide du chiffre d’affaires 1 à +9,7 % au S1, avec un T2 à +8,7 % Rentabilité en hausse, avec un résultat opérationnel ajusté 1,2 progressant de +15 % Chiffre d’affaires du Groupe en hausse de +9,7 % au S1 [...]
Colorectal Cancer Doesn’t Care How Young You Are
28/07/2026
Alliance’s Never Too Young Taskforce Tackles Growing Crisis as Cases of the Deadliest Cancer Continue to Rise in People Under 50 Key Takeaways: This August, World Cancer Support Month, the Colorectal Cancer Alliance ( [...]
North Texas Plastic Surgery’s Dr. Sacha Obaid Named to Newsweek’s America’s Best Plastic Surgeons 2025 List
28/07/2026
Recognition spans five procedure categories, including breast augmentation, liposuction, rhinoplasty, eyelid surgery and tummy tuck SOUTHLAKE, Texas, July 28, 2026 (GLOBE NEWSWIRE) -- North Texas Plastic Surgery [...]
Eurobio Scientific: Premier semestre 2026, Continuation de la transformation stratégique
28/07/2026
PREMIER SEMESTRE 2026, CONTINUATION DE LA TRANSFORMATION STRATEGIQUE Progression du chiffre d’affaires semestriel de 5% à 84,5 M€ Continuation de la stratégie du Groupe : Produits propriétaires : 37% du Chiffre d’ [...]
EssilorLuxottica: Q2/H1 2026 Results - Solid revenue trajectory at +9.7% in H1, with Q2 at +8.7%. Increasing profitability, with Adj. Operating Profit +15%.
28/07/2026
Solid revenue 1 trajectory at +9.7% in H1, with Q2 at +8.7% Increasing profitability, with Adj. Operating Profit 1,2 +15% Group’s revenue grew 9.7% in H1 at constant exchange rates 1 , with Q2 at +8.7% Retail comparable [...]
Eurobio Scientific: First half of 2026, Continuation of the strategic transformation
28/07/2026
FIRST HALF OF 2026, CONTINUATION OF THE STRATEGIC TRANSFORMATION First-half revenue up 5% to €84.5 million Continuation of the Group’s strategy: Proprietary products: 37% of revenue International expansion: 47% of [...]
SodaSlim Introduces a Gummy Supplement Format as Part of Its Portfolio Expansion
28/07/2026
SodaSlim Gummies expand the company’s product portfolio following a coordinated development cycle covering formulation design, production planning, packaging preparation and quality review. New York City, July 28, 2026 [...]
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
28/07/2026
Consolidated net revenue of € 1,410.8 million in the first half of 2026, +6.6% or +9.1% on a like-for-like basis ( 3) at constant exchange rates (CER); adverse FX impact of € 34.5 million (-2.6%) EBITDA ( 1) of € 540.2 [...]
AscellaHealth Appoints Industry Veteran Johanna van Nijkerk as Vice President of Business Development to Advance National Accounts and Drive Growth of AscellaOne
28/07/2026
BERWYN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a full-spectrum pharmacy solutions provider rooted in specialty pharmacy expertise, today announces the appointment of Johanna van Nijkerk as vice president [...]
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
28/07/2026
– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week – – These two peptides have attracted growing scientific interest for their [...]
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
28/07/2026
- Survey findings highlight the prevalence of knee pain, reported impacts on work and quality of life, and strong interest in long-lasting, non-opioid treatment options - BRISBANE, Calif., July 28, 2026 (GLOBE NEWSWIRE [...]
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
28/07/2026
SEATTLE, July 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended [...]
BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms
28/07/2026
Revised agreement provides BiomX with additional flexibility to support Zorronet while further aligning BiomX and Water IO around Zorronet's long-term success NETANYA, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- BiomX Inc [...]
Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
28/07/2026
Company expects to initiate enrollment in TEMPO-1 in September 2026 OPSCC is estimated to represent 1 in 2 head and neck cancer patients in the 2L setting in the U.S. with approximately 14,000 patients eligible annually [...]
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
28/07/2026
The six-month pilot is designed to evaluate the potential scalability of bringing physician-ordered, blood-based OkaiDx laboratory-developed tests to patients in Canada Taipei, Taiwan, July 28, 2026 (GLOBE NEWSWIRE) -- [...]
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
28/07/2026
BRIDGEWATER N.J., July 28, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 a.m. ET on Tuesday, [...]
New Survey: Digestive Side Effects Cause 41% of GLP-1 Users to Suffer in Silence, Self-Adjust, or Consider Quitting
28/07/2026
Of these users, 1 in 5 believe incorrectly that GI side effects are just the price to pay, while others are quietly adjusting their own doses or stopping these popular drugs NEW YORK , July 28, 2026 (GLOBE NEWSWIRE) -- [...]
Slate Medicines Establishes Clinical and Scientific Advisory Boards to Advance Next-Generation Migraine Prevention Therapeutics
28/07/2026
Leading neurologists and researchers to provide strategic and clinical guidance as Slate Medicines progresses SLTE-1009 and a broader pipeline of migraine therapeutics. RALEIGH, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- [...]
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
28/07/2026
CLEARWATER, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body [...]

Pages